AXL and cancer: In light of the oncogenic functions of AXL, clinical trials targeting AXL with different means, such as small molecular inhibitors, antibody-drug conjugates, and monoclonal antibodies have been conducted to evaluate the therapeutic potential of AXL inhibition for anti-cancer treatment [55].